2026-2027 | Live Session | Opioid Use Disorder: Board Review | September 2026
Availability
Registration Required
Online Meeting
Sep 23, 2026 1:00 PM - 3:00 PM CT
Cost
$0.00
Included with ACAAM membership. Join ACAAM to access this and other educational offerings.

ACAAM Members, select "Get Started" to register for this session.

This live session provides a focused, case-based review of opioid use disorder, emphasizing evidence-based assessment, treatment, and management strategies across clinical settings.

What This Includes

• Epidemiology, patterns of use, and evolving trends in the opioid epidemic
• Pharmacology and diagnostic criteria for opioid use disorder
• The impact of stigma on patient engagement, treatment, and recovery outcomes
• Recognition and management of opioid intoxication, withdrawal, and overdose
• Medications for opioid use disorder, including methadone, buprenorphine, and naltrexone
• Practical approaches to medication initiation, titration, and treatment selection across care settings
• Harm reduction and overdose prevention strategies
• Management of co-occurring conditions, including chronic pain, in patients with opioid use disorder

What to Expect

• Live, faculty-led instruction delivered in an interactive online format
• Case-based discussion highlighting real-world clinical decision-making
• Structured content aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas
• Emphasis on high-yield concepts for board review and clinical application
• Practical guidance on delivering evidence-based care across a range of treatment settings

Natalie Buslach, MD
Dr. Buslach is an Assistant Professor of Medicine in the Division of General Internal Medicine at Montefiore Medical Center and Albert Einstein College of Medicine. She serves as Medical Director of the Bridge Clinic at CFCC and Co‑Director of the Interdisciplinary Substance Use Disorder Fellowship.
Laila Khalid, MD MPH
Dr. Khalid is an Associate Professor of Medicine in the Division of General Internal Medicine at Montefiore Medical Center and Albert Einstein College of Medicine. She serves as Program Director of the Addiction Medicine Fellowship and holds leadership roles in the Buprenorphine Treatment Network, Opioid Overdose Prevention Program, and chronic pain care.
Ruchi Shah, DO
Dr. Shah is an Assistant Professor of Medicine in the Division of General Internal Medicine at Montefiore Medical Center and Albert Einstein College of Medicine. She serves as Medical Director of the Addiction Medicine Consult Service at Wakefield Hospital.
Melissa Stein, MD
Dr. Stein is Medical Director of the Division of Services for Addiction at Montefiore Medical Center and an Associate Professor of Medicine and Psychiatry & Behavioral Science at Albert Einstein College of Medicine. She also provides clinical care through Montefiore-affiliated programs, including the Port Morris Wellness Center.
The session recording will be made available in the corresponding On-Demand course after processing. Access the recording through the On-Demand section of the ACAAM Learning Portal.

To support a meaningful learning experience and recognize your participation:

  • After viewing a minimum of [60] minutes of the session, the evaluation will become available
  • We encourage you to complete the evaluation to reflect on the content and provide valuable feedback
  • Upon completion, a Certificate of Participation will be issued for your records
Powered By